Return to Home

Caleres, Inc.

CAL

Find Out if You Qualify for a Financial Reward by filling out the form below.

Caleres, Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Caleres reported its second quarter 2024 on September 12, 2024. The Company reported sales below analyst expectations and also lowered its yearly guidance. Following on this news, shares of Caleres fell over 19% in intraday trading on the same day. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Find More Cases

Ticker Symbol Company Name Join Deadline
IOVA Iovance Biotherapeutics, Inc. July 14, 2025 Join
OGN Organon & Co. July 22, 2025 Join
VSTS Vestis Corporation August 08, 2025 Join
RCKT Rocket Pharmaceuticals, Inc. August 11, 2025 Join
CNC Centene Corporation September 08, 2025 Join